Orexigenic hormone ghrelin ameliorates gut barrier dysfunction in sepsis in rats

Critical Care Medicine

Volumn 37, Issue 8, 2009, Pages 2421-2426

  Wu, Rongqian ^a   Dong, Weifeng ^a   Qiang, Xiaoling ^a   Wang, Haichao ^a   Blau, Steven A ^a   Ravikumar, Thanjavur S ^a   Wang, Ping ^a  

^a NONE

Author keywords

Ghrelin; Gut barrier function; Sepsis

Indexed keywords

GHRELIN; HIGH MOBILITY GROUP B1 PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BACTERIAL TRANSLOCATION; BRAIN LEVEL; CONTINUOUS INFUSION; CONTROLLED STUDY; ILEUM MUCOSA; INFLAMMATION; INTESTINE MUCOSA PERMEABILITY; MALE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SEPSIS; VAGOTOMY;

EID: 68249101621     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e3181a557a2     Document Type: Article

References (60)

1. Angus DC, Linde-Zwirble WT, Lidicker J, et al: Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001; 29:1303-1310
2. Carlet J, Cohen J, Calandra T, et al: Sepsis: time to reconsider the concept. Crit Care Med 2008; 36:964-966
3. Fink MP: Effect of critical illness on microbial translocation and gastrointestinal mucosa permeability. Semin Respir Infect 1994; 9:256-260
4. Doig CJ, Sutherland LR, Sandham JD, et al: Increased intestinal permeability is associated with the development of multiple organ dysfunction syndrome in critically ill ICU patients. Am J Respir Crit Care Med 1998; 158:444-451
5. Magnotti LJ, Deitch EA: Burns, bacterial translocation, gut barrier function, and failure. J Burn Care Rehabil 2005; 26:383-391
6. Swank GM, Deitch EA: Role of the gut in multiple organ failure: bacterial translocation and permeability changes. World J Surg 1996; 20:411-417
7. Kojima M, Hosoda H, Date Y, et al: Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999; 402: 656-660
8. Kojima M, Kangawa K: Ghrelin: structure and function. Physiol Rev 2005; 85:495-522
9. Wang G, Lee HM, Englander E, et al: Ghrelin-not just another stomach hormone. Regul Pept 2002; 105:75-81
10. Wu R, Dong W, Cui X, et al: Ghrelin downregulates proinflammatory cytokines in sepsis through activation of the vagus nerve. Ann Surg 2007; 245:480-486
11. Wu R, Zhou M, Cui X, et al: Upregulation of cardiovascular ghrelin receptor occurs in the hyperdynamic phase of sepsis. Am J Physiol Heart Circ Physiol 2004; 287:H1296-H1302
12. Wu R, Dong W, Zhou M, et al: Ghrelin improves tissue perfusion in severe sepsis via downregulation of endothelin-1. Cardiovasc Res 2005; 68:318-326
13. Wu R, Dong W, Zhou M, et al: Ghrelin attenuates sepsis-induced acute lung injury and mortality in rats. Am J Respir Crit Care Med 2007; 176:805-813
14. Wu R, Zhou M, Das P, et al: Ghrelin inhibits sympathetic nervous activity in sepsis. Am J Physiol Endocrinol Metab 2007; 293: E1697-E1702
15. Wang H, Bloom O, Zhang M, et al: HMG-1 as a late mediator of endotoxin lethality in mice. Science 1999; 285:248-251
16. Andersson U, Wang H, Palmblad K, et al: High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. J Exp Med 2000; 192:565-570
17. Sunden-Cullberg J, Norrby-Teglund A, Rouhiainen A, et al: Persistent elevation of high mobility group box-1 protein (HMGB1) in patients with severe sepsis and septic shock. Crit Care Med 2005; 33:564-573
18. Fiuza C, Bustin M, Talwar S, et al: Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells. Blood 2003; 101:2652-2660
19. Yang H, Ochani M, Li J, et al: Reversing established sepsis with antagonists of endogenous high-mobility group box 1. Proc Natl Acad Sci U S A 2004; 101:296-301
20. Wang H, Liao H, Ochani M, et al: Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis. Nat Med 2004; 10:1216-1221
21. Sappington PL, Yang R, Yang H, et al: HMGB1 B box increases the permeability of Caco-2 enterocytic monolayers and impairs intestinal barrier function in mice. Gastroenterology 2002; 123:790-802
22. Yang R, Harada T, Mollen KP, et al: Anti-HMGB1 neutralizing antibody ameliorates gut barrier dysfunction and improves survival after hemorrhagic shock. Mol Med 2006; 12:105-114
23. Chavez AM, Menconi MJ, Hodin RA, et al: Cytokine-induced intestinal epithelial hyperpermeability: role of nitric oxide. Crit Care Med 1999; 27:2246-2251
24. Yang R, Han X, Uchiyama T, et al: IL-6 is essential for development of gut barrier dysfunction after hemorrhagic shock and resuscitation in mice. Am J Physiol Gastrointest Liver Physiol 2003; 285:G621-G629
25. Wu R, Dong W, Ji Y, et al: Orexigenic hormone ghrelin attenuates local and remote organ injury after intestinal ischemiareperfusion. PLoS ONE 2008; 3:e2026
26. Bernik TR, Friedman SG, Ochani M, et al: Pharmacological stimulation of the cholinergic antiinflammatory pathway. J Exp Med 2002; 195:781-788
27. Borovikova LV, Ivanova S, Zhang M, et al: Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 2000; 405:458-462
28. Strober W, Fuss I, Mannon P: The fundamental basis of inflammatory bowel disease. J Clin Invest 2007; 117:514-521
29. Zayat M, Lichtenberger LM, Dial EJ: Pathophysiology of LPS-induced gastrointestinal injury in the rat: role of secretory phospholipase A2. Shock 2008; 30:206-211
30. Gosain A, Gamelli RL: Role of the gastrointestinal tract in burn sepsis. J Burn Care Rehabil 2005; 26:85-91
31. Cowley MA, Grove KL: Ghrelin-satisfying a hunger for the mechanism. Endocrinology 2004; 145:2604-2606
32. Hattori N, Saito T, Yagyu T, et al: GH, GH receptor, GH secretagogue receptor, and ghrelin expression in human T cells, B cells, and neutrophils. J Clin Endocrinol Metab 2001; 86:4284-4291
33. Papotti M, Ghe C, Cassoni P, et al: Growth hormone secretagogue binding sites in peripheral human tissues. J Clin Endocrinol Metab 2000; 85:3803-3807
34. Shuto Y, Shibasaki T, Wada K, et al: Generation of polyclonal antiserum against the growth hormone secretagogue receptor (GHS-R): evidence that the GHS-R exists in the hypothalamus, pituitary and stomach of rats. Life Sci 2001; 68:991-996
35. Sakata I, Yamazaki M, Inoue K, et al: Growth hormone secretagogue receptor expression in the cells of the stomach-projected afferent nerve in the rat nodose ganglion. Neurosci Lett 2003; 342:183-186
36. Taub DD: Novel connections between the neuroendocrine and immune systems: the ghrelin immunoregulatory network. Vitam Horm 2008; 77:325-346
37. Dixit VD, Schaffer EM, Pyle RS, et al: Ghrelin inhibits leptin- and activation-induced proin-flammatory cytokine expression by human monocytes and T cells. J Clin Invest 2004; 114:57-66
38. Unno N, Wang H, Menconi MJ, et al: Inhibition of inducible nitric oxide synthase ameliorates endotoxin-induced gut mucosal barrier dysfunction in rats. Gastroenterology 1997; 113:1246-1257
39. Deitch EA, Ma L, Ma WJ, et al: Inhibition of endotoxin-induced bacterial translocation in mice. J Clin Invest 1989; 84:36-42
40. De B, I, Deutz NE, van der Hulst RR, et al: Glutamine depletion and increased gut permeability in nonanorectic, non-weightlosing tumor-bearing rats. Gastroenterology 1997; 112:118-126
41. Bianchi ME, Beltrame M, Paonessa G: Specific recognition of cruciform DNA by nuclear protein HMG1. Science 1989; 243: 1056-1059
42. Bianchi ME, Beltrame M: Upwardly mobile proteins: workshop: the role of HMG proteins in chromatin structure, gene expression and neoplasia. EMBO Rep 2000; 1:109-114
43. Rendon-Mitchell B, Ochani M, Li J, et al: IFN-gamma induces high mobility group box 1 protein release partly through a TNFdependent mechanism. J Immunol 2003; 170:3890-3897
44. Liu S, Stolz DB, Sappington PL, et al: HMGB1 is secreted by immunostimulated enterocytes and contributes to cytomixinduced hyperpermeability of Caco-2 monolayers. Am J Physiol Cell Physiol 2006; 290: C990-C999
45. Scaffidi P, Misteli T, Bianchi ME. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 2002; 418: 191-195
46. Li J, Kokkola R, Tabibzadeh S, et al: Structural basis for the proinflammatory cytokine activity of high mobility group box 1. Mol Med 2003; 9:37-45
47. Wang H, Yu M, Ochani M, et al: Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature 2003; 421:384-388
48. Tracey KJ: The inflammatory reflex. Nature 2002; 420:853-859
49. Borovikova LV, Ivanova S, Nardi D, et al: Role of vagus nerve signaling in CNI-1493-mediated suppression of acute inflammation. Auton Neurosci 2000; 85:141-147
50. Date Y, Murakami N, Toshinai K, et al: The role of the gastric afferent vagal nerve in ghrelin-induced feeding and growth hormone secretion in rats. Gastroenterology 2002; 123:1120-1128
51. Banks WA, Tschop M, Robinson SM, et al: Extent and direction of ghrelin transport across the blood-brain barrier is determined by its unique primary structure. J Pharmacol Exp Ther 2002; 302:822-827
52. Wu R, Zhou M, Cui X, et al: Ghrelin clearance is reduced at the late stage of polymicrobial sepsis. Int J Mol Med 2003; 12: 777-781
53. Diano S, Farr SA, Benoit SC, et al: Ghrelin controls hippocampal spine synapse density and memory performance. Nat Neurosci 2006; 9:381-388
54. Cowley MA, Smith RG, Diano S, et al: The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis. Neuron 2003; 37:649-661
55. Chorny A, Anderson P, Gonzalez-Rey E, et al: Ghrelin protects against experimental sepsis by inhibiting high-mobility group box 1 release and by killing bacteria. J Immunol 2008; 180:8369-8377
56. Xu DZ, Lu Q, Deitch EA: Nitric oxide directly impairs intestinal barrier function. Shock 2002; 17:139-145
57. Deitch EA, Shorshtein A, Houghton J, et al: Inducible nitric oxide synthase knockout mice are resistant to diet-induced loss of gut barrier function and intestinal injury. J Gastrointest Surg 2002; 6:599-605
58. Han X, Fink MP, Yang R, et al: Increased iNOS activity is essential for intestinal epithelial tight junction dysfunction in endotoxemic mice. Shock 2004; 21:261-270
59. El Eter E, Al Tuwaijiri A, Hagar H, et al: In vivo and in vitro antioxidant activity of ghrelin: attenuation of gastric ischemic injury in the rat. J Gastroenterol Hepatol 2007; 22:1791-1799
60. Sibilia V, Pagani F, Rindi G, et al: Central ghrelin gastroprotection involves nitric oxide/ prostaglandin cross-talk. Br J Pharmacol 2008; 154:688-697